Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future
- 30 September 1983
- journal article
- clinical trial
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 10 (3), 159-172
- https://doi.org/10.1016/0305-7372(83)90030-0
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaCancer, 1982
- Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC)Cancer Chemotherapy and Pharmacology, 1982
- Therapy of advanced squamous carcinoma of the lung.Cyclophosphamide versus “COMB”Cancer, 1977
- Phase II evaluation of bleomycin.A Southwest Oncology Group studyCancer, 1976
- CCNU and bleomycin in the treatment of cancer: A southwest oncology group studyMedical and Pediatric Oncology, 1975
- Adriamycin in advanced bronchogenic carcinomaCancer, 1974
- CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II studyCancer, 1973
- Results of a clinical trial with intermittent doses of adriamycin in lung cancerEuropean Journal of Cancer (1965), 1972
- COMPARISON OF TREATMENT POLICIES IN INOPERABLE BRONCHIAL CARCINOMAThe Lancet, 1971
- Hexamethylmelamine (NSC-13875) in the treatment of primary cancer of the lung with metastasisCancer, 1968